Clinical Research Partners
Clinical Research Partners is a private multi-site clinical research organization operating three locations in the greater Richmond, Virginia area, conducting Phase 1-4 trials across multiple therapeutic areas on behalf of pharmaceutical and biotech sponsors including Pfizer, Eli Lilly, and Supernus.
- Company typePrivate
- Founded2011
- HeadquartersRichmond, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Clinical Research Partners does
Clinical Research Partners is a private, founder-owned clinical research site organization headquartered in Richmond, Virginia, operating three sites across the greater Richmond-Petersburg-North Chesterfield corridor (Forest Avenue, Medical Park Blvd in Petersburg, and Koger Center Blvd in North Chesterfield). Founded in July 2011 by Dr. Robert S. Call, MD, CPI (President) and Annette Bennett (CEO) through the merger of Dr. Call's prior Commonwealth Clinical Research Specialists with Bennett's clinical research operations, the company conducts Phase 1 through Phase 4 clinical trials on behalf of pharmaceutical and biotech sponsors across a broad non-oncology therapeutic footprint including allergy, vaccines, gastroenterology, endocrinology/metabolism, dermatology, neurology/pain, pediatrics, respiratory, infectious disease, urology, and women's health.
The company's core physical and operational infrastructure is purpose-built for early-phase and specialized work: an on-site peripheral blood mononuclear cell (PBMC) processing laboratory, a Class II Bio-Safety Cabinet (ISO Class 5) pharmacy, restricted-access investigational product storage with continuous digital temperature monitoring across 2-8°C, ambient, and -80°C/-70°C/-20°C ranges, 15 private exam rooms with sick/well separation, and infusion capability via its sister company Infusion Solutions. The medical director and several investigators hold ACRP Certified Principal Investigator credentials, and the broader investigator network is board-certified across family medicine, pediatrics, psychiatry, gastroenterology, dermatology, pulmonology, infectious disease, and women's health.
Revenue is generated almost entirely through negotiated per-study and per-visit site-services contracts with pharmaceutical and biotech sponsors, with Pfizer, Eli Lilly, and Supernus named as customers and an EVP of Contracts and Budgets leading sponsor negotiations. The site pursues a multi-channel go-to-market: direct-to-consumer recruitment via study landing pages and 24-hour phone lines, a $50-per-enrollment physician referral program plus formal partnerships with five regional medical practices, and an enterprise field-sales motion via a Director of Business Development. Participants are not required to have insurance and receive compensation for time and travel. No revenue, funding, or headcount figures are publicly disclosed.
Clinical Research Partners firmographics
Firmographics- Name
- Clinical Research Partners
- Legal name
- Clinical Research Partners, LLC
- Website
- https://clinicalresearchrva.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Clinical Research Partners is a private multi-site clinical research organization operating three locations in the greater Richmond, Virginia area, conducting Phase 1-4 trials across multiple therapeutic areas on behalf of pharmaceutical and biotech sponsors including Pfizer, Eli Lilly, and Supernus.
- Ownership category
- akta.pro rank
Clinical Research Partners industry classification
Industry- Product category
- Clinical Research Site Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Clinical Research & Trial Central Laboratories (HLAFAMAL), Clinical Trial Financial Management & Payments (Site Budgeting) (HLAGACAM)
Keywords
Where Clinical Research Partners is headquartered
LocationHeadquarters
- HQ city
- Richmond
- HQ country
- United States
- HQ region
- North America
Markets served
Clinical Research Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Others
Revenue model
- Clinical trial site services for pharmaceutical/biotech sponsors: Generates revenue by contracting with pharmaceutical and biotech sponsors (e.g., Pfizer, Eli Lilly, Supernus) to conduct Phase 1–4 clinical trials at its three sites. Compensation typically comes via per-study budgets and per-visit fees negotiated by the EVP of Contracts and Budgets.
- Referral incentive program (outflow): Pays a $50 referral incentive per successful enrollment, funded out of site operating budget — this is an outflow, not a revenue stream.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | — | Volunteer compensation per study visit |
| Other | — | Sponsor contract pricing — quote-based |
| Outcome Based/ Performance | — | Referral reward: $50 per successful enrollment |
Go-to-market motion4 records
Clinical Research Partners product offering
Product offeringCore offering
Clinical Research Partners is a multi-site clinical research organization operating three Central Virginia sites that conduct Phase 1 through Phase 4 clinical trials on behalf of pharmaceutical and biotech sponsors. The company recruits patient volunteers, runs investigational product pharmacy operations, performs on-site PBMC and PK processing, and administers study medications through an affiliated infusion center, while also providing regulatory, quality assurance, and study start-up services for sponsors.
Product overview
Clinical Research Partners is a single-service clinical research site organization (not a modular software platform) operating three locations across the greater Richmond, Virginia area (Forest Avenue in Richmond, Medical Park Blvd in Petersburg, and Koger Center Blvd in North Chesterfield). Founded in July 2011, the company conducts Phase 1 through Phase 4 clinical trials across multiple therapeutic areas as an integrated portfolio of enrolling studies. Its portfolio currently spans the Obesity Oral GLP-1 (EVOLVE-SWITCH), ADHD (SPN-812), Asthma, AVALON Celiac Disease (VTP-1000), C Diff Vaccine, Endometriosis (elaris EM-COC), Group B Strep Maternal Vaccine, Infant Pneumococcal Vaccine, Maternal RSV Vaccine (Pfizer ABRYSVO), Ulcerative Colitis, Diabetes Type 2 GLP-1, Crohn's Disease (STARSCAPE), SUNSCAPE Ulcerative Colitis, ATTAIN-PAD Peripheral Artery Disease, BALANCE IBS (camlipixant), Vitiligo (FPAD), and Pediatric Pneumococcal Vaccine studies. Supporting services include a Patient Forms intake process, a Patient Referral program offering $50 per successful enrollment, and Wellness Resources partnerships with Infusion Solutions and Vita Pure IV.
Differentiator
Problem solved
Functional benefit
Products and services
- Phase 1-4 Clinical Trial Site Services End-to-end Phase 1 through Phase 4 clinical trial site services contracted by pharmaceutical and biotech sponsors (e.g., Pfizer, Eli Lilly, Supernus) across more than 15 therapeutic areas excluding oncology. Includes protocol execution, patient recruitment and enrollment, dosing, data capture, regulatory submissions, and quality assurance. Delivered from three Central Virginia sites (Forest Avenue/Richmond, Petersburg, North Chesterfield).
- PBMC / PK Laboratory Processing Services On-site peripheral blood mononuclear cell (PBMC) processing and pharmacokinetic (PK) laboratory services that allow sponsors to run PK and PBMC studies without shipping samples off-site. Supported by the company's GCP-compliant clinical infrastructure.
- Investigational Product Pharmacy Services Investigational product handling and storage under a Class II Bio-Safety Cabinet (ISO Class 5), including refrigerated (2-8°C) and ULT (-80°C/-70°C/-20°C) freezers with continuous digital temperature monitoring and restricted-access IP storage. Provided to sponsors whose protocols require controlled IP and biological-sample handling.
- Patient Referral Program Formal physician referral program that pays $50 to referring clinicians for each referred individual who is new to CRP and successfully enrolls in a study. Backed by partnerships with regional medical practices (Mitchell Endoscopy Center, Virginia Physicians for Women, Virginia South Psychiatric & Family Services, Virginia Physicians Inc., Infusion Solutions).
- Volunteer Study Participation (Compensated) Consumer-facing study participation offered to local Richmond-area volunteers across active Phase 1-4 protocols. No insurance is required; participants receive free study-related care and monetary compensation for time and travel following each completed visit. Self-qualification via online patient forms, dedicated recruitment phone lines, 24-hour contact numbers, and email intake ([email protected]).
Companies that use Clinical Research Partners
Customer profileIdeal customer profiles2 records
Clinical Research Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Clinical Research Partners partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights5 records
Clinical Research Partners competitors and assessment
Company assessmentDirect peers
- Velocity Clinical Research: Velocity Clinical Research is one of the largest integrated site networks in the U.S., running Phase 1-4 trials across multiple therapeutic areas. Like CRP, it is an SMO-style operator that conducts trials for pharma/biotech sponsors; the difference is scale, with dozens of owned sites versus CRP's three Richmond-area locations.
- Javara: Javara is an integrated clinical research site organization embedded within large medical practices, offering Phase 1-4 trials to pharma sponsors. It is directly comparable to CRP's hybrid model of running trials out of affiliated physician practices (Virginia Physicians for Women, Virginia South Psychiatric, etc.) and using physician referrals to drive enrollment.
- Wake Research: Wake Research is a multi-site SMO network operating across the U.S. conducting Phase 1-4 clinical trials in vaccines, GI, endocrine, dermatology and other therapeutic areas. It is directly comparable to CRP because both operate dedicated research sites outside academic medical centers, run multi-specialty Phase 1-4 portfolios, and recruit via dedicated patient recruitment teams.
- Meridian Clinical Research: Meridian Clinical Research operates a network of dedicated clinical research sites in the Mid-Atlantic and Midwest, conducting Phase 1-4 trials across vaccines, dermatology, GI and endocrine indications. It is a comparable regional SMO peer with a similar multi-site, multi-therapeutic operating model and sponsor relationships (e.g., Pfizer, Lilly).
- Benchmark Research: Benchmark Research is a multi-site SMO running Phase 2-4 trials across vaccines, dermatology, GI, women's health, and pediatrics from sites in Texas, Louisiana and California. It is comparable to CRP as an independent multi-specialty site network that recruits patients directly and runs sponsor-funded trials across a similar therapeutic breadth.
- Optimal Research: Optimal Research is a multi-site clinical research site organization running Phase 1-4 trials in vaccines, dermatology, women's health, and metabolic disease. It is directly comparable to CRP because both operate independent research-only sites, recruit via dedicated phone outreach, and run vaccine and GLP-1-style trials.
- DM Clinical Research: DM Clinical Research operates a network of dedicated research sites across the U.S. running Phase 1-4 trials for pharma sponsors. It is comparable to CRP as a multi-site SMO with a similar therapeutic portfolio, dedicated patient recruitment function, and dependence on top-decile PIs to attract sponsor contracts.
Emerging players
- ClinEdge: ClinEdge is a site network and clinical research services provider that operates dedicated sites and supports SMO operations. It is comparable to CRP because both serve as the operational and recruitment backbone for sponsor trials; ClinEdge adds a software/SaaS layer, whereas CRP is a pure site operator.
Broad incumbents
- Pfizer Clinical Research Unit: Pfizer operates internal Phase 1 clinical research units (e.g., New Haven, Brussels) for early-stage trials. As a top sponsor of CRP (Maternal RSV/ABRYSVO study), Pfizer represents both a customer and a broader incumbent running its own site-based clinical research operations in the same therapeutic categories CRP services.
Regional players
- VCU Massey Comprehensive Cancer Center: VCU Massey is an academic medical center-based clinical research site in Richmond, VA running sponsor-funded trials across a broad therapeutic portfolio. It is a comparable local peer to CRP that competes for sponsor work in the same Richmond geography, though its academic positioning and oncology coverage differ from CRP's independent community-based model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Clinical Research Partners social profiles
Digital presenceClinical Research Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Clinical Research Partners leadership team
Management profileNumber of profiles
Profiles12 records
Clinical Research Partners subsidiaries and ownership
Company hierarchySubsidiaries1 record
Clinical Research Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Clinical Research Partners M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Clinical Research Partners
What does Clinical Research Partners do?
Clinical Research Partners is a multi-site clinical research organization operating three Central Virginia sites that conduct Phase 1 through Phase 4 clinical trials on behalf of pharmaceutical and biotech sponsors. The company recruits patient volunteers, runs investigational product pharmacy operations, performs on-site PBMC and PK processing, and administers study medications through an affiliated infusion center, while also providing regulatory, quality assurance, and study start-up services for sponsors.
Is Clinical Research Partners a public or private company?
Clinical Research Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Clinical Research Partners founded?
Clinical Research Partners was founded in 2011. It employs 11 to 50 people.
Where is Clinical Research Partners based?
Clinical Research Partners is headquartered in Richmond, United States, in the North America region.
How does Clinical Research Partners make money?
Two revenue lines are on record. Clinical trial site services for pharmaceutical/biotech sponsors are the primary driver. The others are referral incentive program (outflow).
Who are Clinical Research Partners's main competitors?
Direct peers on record are Velocity Clinical Research, Javara, Wake Research, Meridian Clinical Research, Benchmark Research, Optimal Research and DM Clinical Research. ClinEdge is listed as an emerging player. Pfizer Clinical Research Unit is listed as a broad incumbent. VCU Massey Comprehensive Cancer Center is listed as a regional player.
Does Clinical Research Partners have an API?
No public API is recorded for Clinical Research Partners.
What industry is Clinical Research Partners in?
Clinical Research Partners's product category is Clinical Research Site Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 54171 and its SIC code is 8731.